Shalini Makawita - Concepedia

Author

Shalini Makawita

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

Katelyn Smith, S Makawita, Shalini Makawita

Publications

746

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center University of Toronto University Health Network Mount Sinai Hospital University of Arizona

About

Shalini Makawita is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, tumor biology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	215
2	Cell Biology	3	3	181
3	Engineering	1	1	31
4	Natural Sciences	1	1	112
5	Biochemistry	1	1	112

Shalini Makawita

Publications

512

Citations

H-Index

Page 1

	Year	Citations
Integrated Proteomic Profiling of Cell Line Conditioned Media and Pancreatic Juice for the Identification of Pancreatic Cancer Biomarkers Shalini Makawita, Christopher R. Smith, Ihor Batruch, Molecular & Cellular Proteomics PathologyTumor BiologyProteomic TechnologyPancreatic JuicePancreatic Cancer	2011	112
Infigratinib in patients with advanced cholangiocarcinoma with <i>FGFR2</i> gene fusions/translocations: the PROOF 301 trial Shalini Makawita, Ghassan K. Abou‐Alfa, Sameek Roychowdhury, Future Oncology	2020	87
Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.9 Shalini Makawita, Apostolos Dimitromanolakis, Antoninus Soosaipillai, BMC Cancer	2013	54
Bioinformatic identification of proteins with tissue-specific expression for biomarker discovery Ioannis Prassas, Caitlin C Chrystoja, Shalini Makawita, BMC Medicine	2012	53
Expression of Insulin-Like Growth Factor Pathway Proteins in Rhabdomyosarcoma: IGF-2 Expression is Associated with Translocation-Negative Tumors Shalini Makawita, Michael Ho, Adam D. Durbin, Pediatric and Developmental Pathology Translocation-negative TumorsIgf Pathway GenesMedicinePathologyIgf1 Expression	2008	38
Mining the malignant ascites proteome for pancreatic cancer biomarkers Hari Kosanam, Shalini Makawita, Bramford Judd, PROTEOMICS	2011	35
Abstract 5075: An integrated <i>in silico</i> and proteomic approach towards the identification of novel cancer biomarkers based on tissue specificity Ioannis Prassas, Shalini Makawita, Eleftherios P. Diamandis Cancer Research EngineeringTissue SpecificityPathologyMultiomicsAbstract 5075	2011	31
Phase II Study of Ramucirumab in Advanced Biliary Tract Cancer Previously Treated By Gemcitabine-Based Chemotherapy Sunyoung Lee, Rachna T. Shroff, Shalini Makawita, Clinical Cancer Research	2022	29
Antibody-Drug Conjugates: Patient and Treatment Selection Shalini Makawita, Funda Meric‐Bernstam American Society of Clinical Oncology Educational Book Patient SelectionImmunologyImmunoeditingBiological TherapyPharmacotherapy	2020	24
Phase II Study of Ramucirumab in Advanced Biliary Tract Cancer Previously Treated By Gemcitabine-Based Chemotherapy. Rachna T. Shroff, Shalini Makawita, Lianchun Xiao, PubMed	2022	17

Page 1